LSB
LakeShore Biopharma
LSB
LSB
Delisted
LSB was delisted on the 19th of September, 2025.
11 hedge funds and large institutions have $3.34M invested in LakeShore Biopharma in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$160K | |
| 2 | +$26.4K | |
| 3 | +$10.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.56K |
Top Sellers
| 1 | -$305K | |
| 2 | -$84.3K | |
| 3 | -$51.9K | |
| 4 |
PAM
Pinpoint Asset Management
Hong Kong
|
-$3.58K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$359 |